These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 37671841)

  • 1. Chemical Modification of Tiopronin for Dual Management of Cystinuria and Associated Bacterial Infections.
    Kumar A; Estes Bright LM; Garren MRS; Manuel J; Shome A; Handa H
    ACS Appl Mater Interfaces; 2023 Sep; 15(37):43332-43344. PubMed ID: 37671841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary excretion of free cystine and the tiopronin-cysteine-mixed disulfide during long term tiopronin treatment of cystinuria.
    Lindell A; Denneberg T; Jeppsson JO
    Nephron; 1995; 71(3):328-42. PubMed ID: 8569983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystinuria in the dog: clinical studies during 14 years of medical treatment.
    Hoppe A; Denneberg T
    J Vet Intern Med; 2001; 15(4):361-7. PubMed ID: 11467594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical course and cystine stone formation during tiopronin treatment.
    Lindell A; Denneberg T; Hellgren E; Jeppsson JO; Tiselius HG
    Urol Res; 1995; 23(2):111-7. PubMed ID: 7676533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of sodium intake on cystinuria with and without tiopronin treatment.
    Lindell A; Denneberg T; Edholm E; Jeppsson JO
    Nephron; 1995; 71(4):407-15. PubMed ID: 8587620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of cystinuria with alpha-mercaptopropionylglycine.
    Johansen K; Gammelgård PA; Jørgensen FS
    Scand J Urol Nephrol; 1980; 14(2):189-92. PubMed ID: 7209424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical study on cystinuria in children--the stone management and the prevention of calculi recurrence].
    Asanuma H; Nakai H; Takeda M; Shishido S; Kawamura T; Nagakura K; Yamafuji M
    Nihon Hinyokika Gakkai Zasshi; 1998 Sep; 89(9):758-65. PubMed ID: 9796255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological interventions for the management of cystinuria: a systematic review.
    Bhatt NP; Deshpande AV; Starkey MR
    J Nephrol; 2024 Mar; 37(2):293-308. PubMed ID: 37957454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary excretion of total cystine and the dibasic amino acids arginine, lysine and ornithine in relation to genetic findings in patients with cystinuria treated with sulfhydryl compounds.
    Fjellstedt E; Harnevik L; Jeppsson JO; Tiselius HG; Söderkvist P; Denneberg T
    Urol Res; 2003 Dec; 31(6):417-25. PubMed ID: 14586528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of increasing doses of cystine-binding thiol drugs on cystine capacity in patients with cystinuria.
    Malieckal DA; Modersitzki F; Mara K; Enders FT; Asplin JR; Goldfarb DS
    Urolithiasis; 2019 Dec; 47(6):549-555. PubMed ID: 30980122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cystine-binding thiol drugs on urinary cystine capacity in patients with cystinuria.
    Dolin DJ; Asplin JR; Flagel L; Grasso M; Goldfarb DS
    J Endourol; 2005 Apr; 19(3):429-32. PubMed ID: 15865542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mercaptopropionylglycine: a progress in cystine stone therapy.
    Hautmann R; Terhorst B; Stuhlsatz HW; Lutzeyer W
    J Urol; 1977 May; 117(5):628-30. PubMed ID: 870714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The long-term outcome of cystinuria in Japan.
    Akakura K; Egoshi K; Ueda T; Nozumi K; Kotake T; Masai M; Ito H
    Urol Int; 1998; 61(2):86-9. PubMed ID: 9873246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of 2-mercaptopropionylglycine and D-penicillamine in the treatment of cystinuria.
    Harbar JA; Cusworth DC; Lawes LC; Wrong OM
    J Urol; 1986 Jul; 136(1):146-9. PubMed ID: 3712602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephrotic syndrome occurring during tiopronin treatment for cystinuria.
    Tasic V; Lozanovski VJ; Ristoska-Bojkovska N; Sahpazova E; Gucev Z
    Eur J Pediatr; 2011 Feb; 170(2):247-9. PubMed ID: 20924604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accurate 24-h urine cystine quantification for patients on cystine-binding thiol drugs.
    Mikel CC; Goldfarb DS; Ponte A; Steigelman K; Latyshev S
    Urolithiasis; 2022 Dec; 50(6):721-727. PubMed ID: 36201021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on cystine stones: current and future concepts in treatment.
    Moussa M; Papatsoris AG; Abou Chakra M; Moussa Y
    Intractable Rare Dis Res; 2020 May; 9(2):71-78. PubMed ID: 32494553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation and Medical Management of Patients with Cystine Nephrolithiasis: A Consensus Statement.
    Eisner BH; Goldfarb DS; Baum MA; Langman CB; Curhan GC; Preminger GM; Lieske JC; Pareek G; Thomas K; Zisman AL; Papagiannopoulos D; Sur RL
    J Endourol; 2020 Nov; 34(11):1103-1110. PubMed ID: 32066273
    [No Abstract]   [Full Text] [Related]  

  • 19. [Long-term study of tiopronin in patients with cystinuria].
    Koide T; Yoshioka T; Miyake O; Okuyama A; Yachiku S
    Hinyokika Kiyo; 2003 Feb; 49(2):115-20. PubMed ID: 12696195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. α-Lipoic Acid (ALA) Improves Cystine Solubility in Cystinuria: Report of 2 Cases.
    Cil O; Perwad F
    Pediatrics; 2020 May; 145(5):. PubMed ID: 32245805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.